Testing the Addition of a New Anti-cancer Drug, M3814, to Radiation Therapy for Localized Pancreatic Cancer

Author(s):  
2018 ◽  
Vol 109 (4) ◽  
pp. 1135-1146 ◽  
Author(s):  
Norihiko Sasaki ◽  
Toshiyuki Ishiwata ◽  
Fumio Hasegawa ◽  
Masaki Michishita ◽  
Hiroki Kawai ◽  
...  

2004 ◽  
Vol 08 (19) ◽  
pp. 1047-1062

AustCancer Licenses Phase I/II Pancreatic Cancer Drug. Peplin Pouched US Patent for Anti-Cancer Compounds. US Government Fund Injection for Biota's Influenza Research. New Licensor for Receptor Mimic Technology. Bionomics and Athena in Epilepsy License Deal. The Emerging China Hospital Industry. New Hope Hepatitis B Patients in China. Tackling Lamivudine Resistant HBV. Solutions to Diabetic Heart Disease. Merck Appoints New NZ Distributor.


Xenobiotica ◽  
2009 ◽  
Vol 00 (00) ◽  
pp. 090901052053001-8
Author(s):  
K. Murai ◽  
H. Yamazaki ◽  
K. Nakagawa ◽  
R. Kawai ◽  
T. Kamataki

2010 ◽  
Author(s):  
N. Magnavita ◽  
I. lavicoli ◽  
V. Leso ◽  
A. Bergamaschi

Sign in / Sign up

Export Citation Format

Share Document